Cargando…
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer
OBJECTIVE: CA 15-3 is a traditional biomarker for advanced breast cancer with limited sensitivity for early stage patients. In order to increase the sensitivity for early detection, in this study, we introduced novel tumor-associated autoantibodies that were measured concurrently with serum CA 15-3...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615893/ https://www.ncbi.nlm.nih.gov/pubmed/23569391 http://dx.doi.org/10.2147/OTT.S43122 |